D. Gilliland

D. Gilliland

Director/Board Member presso NUVALENT, INC.

Patrimonio netto: 2 M $ in data 31/01/2024

69 anni
Health Technology
Commercial Services
Consumer Services

Profilo

D.
Gary Gilliland
is on the board of Laboratory Corp.
of America Holdings and Nuvalent, Inc. and Member of American Academy of Arts & Sciences, Member of National Academy of Medicine (United States), Member of Association of American Physicians and Member of American Society of Clinical Investigation.
In his past career D.
Gary Gilliland
occupied the position of Senior Vice President-Global Oncology Franchise at Merck & Co., Inc. and Senior Vice President of Merck Research Laboratories Massachusetts LLC (a subsidiary of Merck & Co., Inc.), Director-Cancer Stem Cell Program at Harvard Stem Cell Institute, Senior Vice President-Merck Research Laboratories at The University of Pennsylvania Health System, President & Director-Emeritus at Fred Hutchinson Cancer Research Center, Investigator at Howard Hughes Medical Institute, Inc., Director-Leukemia Program at Dana-Farber, Professor-Stem Cell & Regenerative Biology at Harvard Medical School, Vice Dean & Professor at Perelman School of Medicine and Senior Vice President-Merck Research Laboratories at Trustees of the University of Pennsylvania.
D.
Gary Gilliland
received a doctorate from the University of California, Los Angeles, a doctorate from The University of California, San Francisco and an undergraduate degree from the University of California, Davis.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValorizzazioneData di valutazione
07/02/2024 8 712 ( 0.01% ) 2 M $ 31/01/2024
15/06/2023 0 ( -.--% ) - $ 31/01/2024

Posizioni attive di D. Gilliland

SocietàPosizioneInizio
LABORATORY CORPORATION OF AMERICA HOLDINGS Director/Board Member 01/04/2014
NUVALENT, INC. Director/Board Member 01/01/2021
Corporate Officer/Principal -
Corporate Officer/Principal -
American Society of Clinical Investigation Corporate Officer/Principal -
Corporate Officer/Principal -
Tutte le posizioni attive di D. Gilliland

Precedenti posizioni note di D. Gilliland

SocietàPosizioneFine
President 01/02/2020
Perelman School of Medicine Corporate Officer/Principal 01/01/2020
Corporate Officer/Principal 01/01/2015
░░░░░ ░░░░░ ░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░ ░░░░░░░░░░░░ ░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Vedi nel dettaglio l'esperienza di D. Gilliland

Formazione di D. Gilliland

University of California, Los Angeles Doctorate Degree
University of California, Davis Undergraduate Degree
The University of California, San Francisco Doctorate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di D. Gilliland

Relazioni

100 +

Relazioni di 1° grado

20

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa3
LABORATORY CORPORATION OF AMERICA HOLDINGS

Health Services

MERCK & CO., INC.

Health Technology

NUVALENT, INC.

Health Technology

Aziende private12

Commercial Services

Miscellaneous

Commercial Services

Commercial Services

Commercial Services

Health Technology

Health Services

American Society of Clinical Investigation

Health Technology

Miscellaneous

Health Technology

Commercial Services

Vedi le connessioni aziendali
  1. Borsa
  2. Insiders
  3. D. Gilliland
Tutti i resoconti di oltre 9.000 società, il giorno stesso della pubblicazione!
Sbloccali ora!
fermer